| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exagen Inc. (XGN) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 19 sells. XGN is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 175.0K | $615.1K | - | |
| CFO | 60.0K | $210.9K | - | |
| Dir | 18.0K | $63.3K | - | |
| Dir | 13.5K | $47.5K | - | |
| Dir | 9.0K | $31.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2020 | Hunt Holdings Limited Partnership | 10% Owner | Sell | 15,947 | $16.05 | $255,964.78 | -0.4% | |
| Nov 9, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 882 | $16.21 | $14,293.16 | -2.7% | |
| Oct 19, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 6,618 | $15.35 | $101,577.36 | -6.3% | |
| Sep 11, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 15,000 | $12.40 | $186,000.00 | -0.9% | |
| Sep 1, 2020 | Nmsic Co-Investment Fund, L.P. | 10% Owner | Sell | 126,404 | $12.50 | $1,580,050.00 | -4.9% | |
| Aug 18, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 14,987 | $16.61 | $248,969.85 | -0.5% | |
| Jun 9, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 6,882 | $12.87 | $88,557.60 | -0.2% | |
| May 28, 2020 | Tullis James L L73 | Director, 10% Owner | Sell | 5,288 | $12.20 | $64,502.69 | -0.2% | |
| Sep 23, 2019 | H.i.g. Bio-Exagen, L.P. | 10% Owner | Buy | 425,000 | $14.00 | $5,950,000.00 | +33.4% |